|
|
Michael Ristow, Hindrik Mulder, Doreen Pomplun, Tim J. Schulz, Katrin Müller-Schmehl, Anja Krause, Malin Fex, Hélène Puccio, Jörg Müller, Frank Isken, Joachim Spranger, Dirk Müller-Wieland, Mark A. Magnuson, Matthias Möhlig, Michel Koenig, Andreas F.H. Pfeiffer
J Clin Invest. 2003;
112(4):527
doi:10.1172/JCI18107
Abstract |
Full text
| PDF
D
iabetes is caused by an absolute (type 1) or relative (type 2) deficiency of insulin-producing β cells. We have disrupted expression of the mitochondrial protein frataxin selectively in pancreatic β cells. Mice were born healthy but subsequently developed impaired glucose tolerance progressing to overt diabetes mellitus. These observations were explained by impairment of insulin secretion due to a loss of β cell mass in knockout animals. This phenotype was preceded by elevated levels of reactive oxygen species in knockout islets, an increased frequency of apoptosis, and a decreased number of proliferating β cells. Hence, disruption of the frataxin gene in pancreatic β cells causes diabetes following cellular growth arrest and apoptosis, paralleled by an increase in reactive oxygen species in islets. These observations might provide insight into the deterioration of β cell function observed in different subtypes of diabetes in humans.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(8)
| Title and authors |
Publication |
Year |
Silencing of frataxin gene expression triggers p53-dependent apoptosis in human neuron-like cells
G. M. Palomo, T. Cerrato, R. Gargini, J. Diaz-Nido
|
Human Molecular Genetics
|
2011 |
Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxia.
Giovanni Coppola, Daniele Marmolino, Daning Lu, Qing Wang, Miriam Cnop, Myriam Rai, Fabio Acquaviva, Sergio Cocozza, Massimo Pandolfo, Daniel H Geschwind
|
Human Molecular Genetics
|
2009 |
Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia
A. Campanella, E. Rovelli, P. Santambrogio, A. Cozzi, F. Taroni, S. Levi
|
Human Molecular Genetics
|
2008 |
The gene responsible for Dyggve-Melchior-Clausen syndrome encodes a novel peripheral membrane protein dynamically associated with the Golgi apparatus
A. Dimitrov, V. Paupe, C. Gueudry, J.-B. Sibarita, G. Raposo, O. Vielemeyer, T. Gilbert, Z. Csaba, T. Attie-Bitach, V. Cormier-Daire, P. Gressens, P. Rustin, F. Perez, V. El Ghouzzi
|
Human Molecular Genetics
|
2008 |
Reduced expression of mitochondrial frataxin in mice exacerbates diet-induced obesity
D. Pomplun, A. Voigt, T. J. Schulz, R. Thierbach, A. F. Pfeiffer, M. Ristow
|
Proceedings of the National Academy of Sciences
|
2007 |
Improved glucose metabolism in mice lacking α-tocopherol transfer protein
Marc Birringer, Doreen Kuhlow, Paul T. Pfluger, Nico Landes, Tim J. Schulz, Markus Glaubitz, Simone Florian, Andreas Pfeiffer, Markus Schuelke, Regina Brigelius-Flohé, Michael Ristow
|
Eur J Nutr
|
2007 |
Pancreatic deletion of insulin receptor substrate 2 reduces beta and alpha cell mass and impairs glucose homeostasis in mice
J. Cantley, A. I. Choudhury, H. Asare-Anane, C. Selman, S. Lingard, H. Heffron, P. Herrera, S. J. Persaud, D. J. Withers
|
Diabetologia
|
2007 |
The role of mitochondria in inherited neurodegenerative diseases
Jennifer Q. Kwong, M. Flint Beal, Giovanni Manfredi
|
Journal of Neurochemistry
|
2006 |
|